Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. (2017)

First Author: Barbieri I
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nature24678

PubMed Identifier: 29186125

Publication URI: http://europepmc.org/abstract/MED/29186125

Type: Journal Article/Review

Volume: 552

Parent Publication: Nature

Issue: 7683

ISSN: 0028-0836